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Abstract
Background: Similarities between obsessive-compulsive disorder (OCD) and trichotillomania
(TTM) have been widely recognized. Nevertheless, there is evidence of important differences
between these two disorders. Some authors have conceptualized the disorders as lying on an OCD
spectrum of conditions.
Methods: Two hundred and seventy eight OCD patients (n = 278: 148 male; 130 female) and 54
TTM patients (n = 54; 5 male; 49 female) of all ages were interviewed. Female patients were
compared on select demographic and clinical variables, including comorbid axis I and II disorders,
and temperament/character profiles.
Results: OCD patients reported significantly more lifetime disability, but fewer TTM patients
reported response to treatment. OCD patients reported higher comorbidity, more harm
avoidance and less novelty seeking, more maladaptive beliefs, and more sexual abuse. OCD and
TTM symptoms were equally likely to worsen during menstruation, but OCD onset or worsening
was more likely associated with pregnancy/puerperium.
Conclusions: These findings support previous work demonstrating significant differences
between OCD and TTM. The classification of TTM as an impulse control disorder is also
problematic, and TTM may have more in common with conditions characterized by stereotypical
self-injurious symptoms, such as skin-picking. Differences between OCD and TTM may reflect
differences in underlying psychobiology, and may necessitate contrasting treatment approaches.
Background
Trichotillomania (TTM) is characterized by repetitive ster-
eotypical hair-pulling from different sites resulting in
noticeable hair loss [1]. Phenomenological observations
have suggested that symptoms of repetitive hair-pulling
are reminiscent of the compulsions seen in obsessive-
compulsive disorder (OCD) [2,3]. For example, both TTM
and OCD patients describe compulsive urges and ritualis-
tic behaviours [2,4]. Comorbidity data also suggest some
overlap between TTM and OCD [2]. Thus, a number of
authors have suggested that TTM might be classified with
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nology [4-8].
However, in addition to overlapping phenomenology
between OCD and TTM, there are also significant differ-
ences. For example, in contrast to compulsions in OCD,
hair-pulling in TTM is not in response to obsessive
thoughts (such as worry about harm to self or others) but
rather because of an irresistible urge and the promise of
gratification when pulling out hair [2,6]. Also, unlike
patients with OCD whose symptoms change over time in
terms of focus and severity (e.g. from washing of hands to
checking locks, stoves, appliances, etc) [9], TTM patients
usually only present with hair-pulling without evolution
to non-self-injurious compulsive rituals.
Examination of demographic variables in OCD and TTM
supports the argument that these are two distinctive disor-
ders. TTM is much more prevalent in females (10:1 female
to male ratio) [10] whereas OCD is equally common in
males and females [11]. Age of onset also differs some-
what: TTM typically presents in early adolescence, with
the mean age of onset of hair-pulling in males later than
that in females [10,12,13] whereas OCD has its onset
from childhood through to early adulthood [14], but with
males reporting an earlier onset compared to females
[15].
Additional clinical observations further support a distinc-
tion between OCD and TTM. Patients with TTM tend to
have fewer comorbid obsessive-compulsive symptoms, as
well as less depression and anxiety compared to OCD
patients [16]. Response prevention in OCD patients even-
tually leads to anxiety reduction, whereas in people with
TTM it may lead to an increase in anxiety [17]. Although a
selective response to serotonergic reuptake inhibitors
(SRI's) has been suggested to characterize both OCD and
TTM, there is good evidence that response to SRI's is sus-
tained in OCD, whereas the evidence-base for the efficacy
of these agents in TTM is much more mixed.
Relatively few empirical studies have, however, docu-
mented the phenomenological similarities and differ-
ences between OCD and TTM [3,18,19]. A large clinical
database comprised of patients with OCD and TTM pro-
vided us an opportunity to investigate the relationship
between these conditions in terms of demographic and
clinical variables.
Methods
Subjects
Two hundred and seventy eight OCD patients (n = 278:
148 male; 130 female), and 54 TTM patients (n = 54; 5
male; 49 female), ranging in age between 8 and 75 years,
took part in the study (Table 1). These patients were
referred to our research unit from a wide range of sources
(including the OCD Association of South Africa, commu-
nity based primary care practitioners, and psychiatrists).
Either a clinical psychologist or a psychiatrist with exper-
tise in the field interviewed participants. Participants met
the Diagnostic and Statistical Manual of Mental Disorders
(DSM-IV) criteria [1] for either a primary diagnosis of
OCD or TTM on the Structured Clinical Interview for Axis
I Disorders (SCID-I) [20]. Patients were included irrespec-
tive of whether they were at baseline (i.e. not receiving any
form of treatment for their primary psychiatric disorder),
or were receiving treatment for OCD / TTM, but those
with comorbid OCD and TTM (N = 25) were excluded
from subsequent analysis. A history of psychosis was also
an exclusion criterion. Referring clinicians were contacted
to establish, where possible, a longitudinal expert evalua-
tion of the diagnostic status of the patient. All subjects
gave informed written consent to participate after confi-
dentiality was guaranteed and risks and benefits had been
fully explained. The study was approved by the Institu-
tional Review Board of the University of Stellenbosch.
Interview
Specific demographic data, including age when inter-
viewed, age of onset of OCD/TTM, highest level of educa-
tion, current employment status, and population group
Table 1: Demographic information: OCD and TTM
Variables OCD (N = 278) TTM (N = 54) χ2 P
Gender 148 male 130 female 5 male 49 female 40.7 <.001
Age (SD) 33.1 (14.4) 31.3 (12.5) NS
Population group 86.6% Caucasian 79.6% Caucasian NS
Level of education 50.7% completed high school or higher level 
education
44.4% completed high school or higher level 
education
NS
Employment 6.8% unemployed 3.7% unemployed NS
NS = non-significantPage 2 of 10
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SCID-I, and selected parts of the SCID-II (obsessive-com-
pulsive, avoidant, schizotypal, borderline personality dis-
orders) for adult patients (aged 18 or older) [20], the
interview also included the Structured Clinical Interview
for Obsessive-Compulsive Spectrum Disorders (SCID-
OCSD) to determine the presence of other obsessive-com-
pulsive related conditions [21].
The Yale-Brown Obsessive-Compulsive Severity Scale (Y-
BOCS) [22] was implemented to assess the severity of
OCD symptoms. Severity of hair-pulling symptoms was
assessed with the Massachusetts General Hospital Hair-
pulling Scale [23]. The Trichotillomania Behaviour Profile
(TBP, available from the first author on request) was
administered to TTM patients to assess hair-pulling
phenomenology.
Patients' level of insight into the senselessness or exces-
siveness of their symptoms was assessed on the relevant
YBOCS item. When an adequate trial of pharmacotherapy
with an SRI (i.e. for both OCD and TTM groups, at least
10 weeks on the medication with a minimum of 6 weeks
on mid-range dose) had been undertaken, response to
pharmacotherapy was assessed using the global improve-
ment item of the Clinical Global Impression (CGI) scale;
subjects with CGI scores of 1 ('very much improved') or 2
('much improved') were defined as responders [24]. Sim-
ilarly, when patients received an adequate trial of cogni-
tive behavioural therapy (CBT) (i.e. for both OCD and
TTM groups, 8 or more sessions with an expert CBT psy-
chotherapist), response to treatment was rated using the
CGI. The Disability Profile questionnaire (DP) [25] was
included in the interview to assess current (i.e. past two
weeks) and lifetime impairment in eight domains. The DP
was initially developed for use in patients with social anx-
iety disorder; nevertheless, the scale has since been used to
assess disability in patients with other anxiety disorders as
well [26].
Questions addressing potential precipitating or exacerbat-
ing factors, including the impact of menstrual/reproduc-
tive cycle changes, brain trauma and history of
autoimmune infections on OCD/TTM symptom fluctua-
tions, were included in the interview.
Self-report questionnaires
Severity of comorbid depression was evaluated with the
Beck Depression Inventory (BDI) [27]. The Childhood
Trauma Questionnaire (CTQ) [28], a scale proven to be a
valid and reliable measure of past traumatic experiences
[29], was used as a self-report questionnaire to assess the
nature and severity of childhood trauma. Sub-scales of the
CTQ include measures of emotional abuse, physical
abuse, sexual abuse, emotional neglect and physical
neglect.
The self-report Temperament and Character Inventory
(TCI) [30] was also used to measure behaviours associ-
ated with seven personality dimensions, namely novelty
seeking, harm avoidance, reward dependence, persist-
ence, self-directedness, cooperativeness, and self-tran-
scendence. In addition, participants completed the self-
report Young Schema Questionnaire (YSQ) [31] to assess
the current profile of fundamental maladaptive beliefs
(cognitive schemas) in OCD and TTM. For each item of
the 75-item "short form" of the YSQ (which includes 15
schemas), the answer is required to be placed on a 6-point
Likert-type scale (1= 'completely untrue of me', 2 =
'mostly untrue of me', 3 = 'slightly more true than untrue',
4 = 'moderately true of me', 5 = 'mostly true of me', 6 =
'describes me perfectly').
Data analysis
As there were few males with TTM (Table 2), only clinical
data from females with OCD and TTM were analyzed.
Chi-square and t-tests were performed to investigate the
differences in OCD/TTM phenomenology where appro-
priate. A one-way analysis of variance (ANOVA) was done
to investigate the effects of the primary and comorbid dis-
orders on disability. Subsequently, a two-way fixed effects
ANOVA was used to assess the main interactions between
primary diagnosis and comorbidity on disability and to
test for the main (fixed) effects of the different diagnoses
Table 2: Comparison of symptomatology: OCD vs TTM
Variables OCD TTM P
Age of onset (SD) 19.3 (12.0) 11.8 (7.6) <.001
Symptom severity (SD) YBOCS score: 20.1 (8.0); range: 0 – 39 MGHHPS score: 16.1 (6.5); range: 0 – 26
Severity of depressive symptoms (BDI score) 8.9 (11.3) 5.5 (7.2) .04
Poor insight 13.6% 0% NS
Treatment response SRI: 90.7% SRI: 42.9% .003
CBT: 73.3% CBT: 33.3% .02
Tics 12.3% 6.1% NSPage 3 of 10
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data in OCD and TTM groups suggested non-normality of
the data. As a result, pair-wise comparison tests (Mann-
Whitney U) were implemented to compare the two
groups on cognitive schemas.
Results
Demographics
Gender distribution of the sample differed significantly,
with a marked predominance of female participants with
TTM compared to almost equal numbers of male and
female participants with OCD. TTM patients had an ear-
lier age of onset of illness compared to patients with OCD
(Table 2).
Clinical features
Comorbidity
A number of disorders were more frequent in females
with OCD: major depressive disorder (MDD), dysthymia,
panic disorder, hypochondriasis and intermittent explo-
sive disorder. In terms of the selected Axis II disorders,
obsessive-compulsive personality disorder (OCPD) was
more frequent in females with OCD (Table 3).
Symptom severity
The severity of OC symptoms in OCD patients, as meas-
ured by the YBOCS severity scale, was 20.1 (± 8.0). TTM
patients scored 16.1 (± 6.5) on average on the MGHHPS.
Compared to TTM patients, females with OCD had signif-
icantly higher depressive symptom scores on the BDI
(Table 2).
Disability
The DP was administered to a total of 95 OCD and 30
TTM patients (Table 4). OCD patients reported signifi-
cantly more lifetime impairment due to their illness than
TTM patients. More specifically, OCD patients were more
impaired in terms of work-related functioning, family
functioning, marriage / dating, activities of daily life, and
other activities (which included religious activities, mem-
bership of clubs, having hobbies, participation in sports
etc.) and had more suicidality. One-way ANOVA's
Table 3: Lifetime comorbidity: OCD vs TTM
Disorder OCD (N = 130) TTM (N = 49) χ2 P
Major depressive disorder 66.9% 49.0% 4.8 .03*
Dysthymia 13.8% 2.0% 6.8 .009**
Bipolar disorder 0.8% 0% 0.6 0.4
Panic disorder 20.8% 6.1% 6.4 .01*
Alcohol abuse 5.4% 2.0% 1.1 0.3
Alcohol dependence 0.8% 0% 0.6 0.4
Substance abuse 0.8% 4.1% 2.0 0.2
Substance dependence 1.5% 2.0% 0.1 0.8
Social phobia 10.0% 8.2% 0.1 0.7
Specific phobia 18.5% 18.4% 0.0 <1.0
Posttraumatic stress disorder 3.1% 0% 2.6 0.1
Generalized anxiety disorder 13.1% 20.4% 1.4 0.2
Body dysmorphic disorder 6.2% 6.1% 0.0 <1.0
Anorexia Nervosa 8.5% 2.0% 2.9 0.1
Bulimia Nervosa 7.7% 6.1% 0.1 0.7
Binge-eating disorder 4.6% 10.2% 1.8 0.2
Hypochondriasis 4.6% 0% 3.9 <.05*
Stereotypic movement disorder 3.5% (N = 85) 0% (N = 18) 1.2 0.3
Tourette's disorder 3.8% 2% 0.4 0.5
Tics 12.3% 6.1% 1.6 0.2
Kleptomania 4.6% 4.1% 0.0 0.9
Pyromania 0% 2.0% 2.6 0.1
Compulsive shopping 6.9% 4.1% 0.5 0.5
Hypersexual disorder 1.5% 0% 1.3 0.3
Intermittent explosive disorder 16.2% 6.1% 3.5 .06
OCPD 39.2% 13.3% 11.3 .001**
Avoidant personality disorder 21.2% (N = 99) 0.03% (N = 26) 2.9 0.9
Schizotypal personality disorder 5.3% (N = 94) 0% (N = 25) 2.4 0.1
Borderline personality disorder 22.3% (N = 94) 8% (N = 49) 3.0 0.1
* p < .05 (2-tailed)
** p < .01 (2-tailed)Page 4 of 10
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(F = 11.84; p = 0.001) and panic disorder (F = 6.73; p =
0.01) had a significant effect on the levels of disability.
However, there was no significant interaction effect
between the primary diagnosis and panic disorder, sug-
gesting that the levels of disability were dependent on pri-
mary diagnosis (either OCD or TTM) (F = 5.79; p = 0.02)
and not influenced by the absence or presence of panic
disorder (F = 0.001; p = 0.98).
Character / Temperament
Compared to OCD patients, patients with TTM scored sig-
nificantly higher on novelty seeking, whereas OCD
patients had significantly greater harm avoidance (Table
5).
Schemas
Fifty-nine OCD and 26 TTM patients fully completed the
YSQ. Pair-wise comparison tests (Mann-Whitney U) indi-
cated that OCD and TTM patients differed significantly on
5 schemas, i.e. mistrust / abuse, social isolation, shame /
defectiveness, subjugation and emotional inhibition
(Table 7). More specifically, OCD patients had
significantly higher scores on each of these schemas com-
pared to TTM patients.
Precipitating factors
Interpersonal trauma history
OCD patients reported more childhood sexual abuse than
did TTM patients (p = .04).
Brain trauma history
OCD and TTM patients did not differ significantly in
terms of a history of serious head injury associated with
the onset of OCD or TTM.
History of autoimmune infections
Compared to none in the TTM group, 9 OCD patients
reported onset of their OCD with an episode of bacterial
pharyngitis (p = .06). In terms of other autoimmune infec-
tions, OCD and TTM patients did not differ significantly.
Table 4: Disability profile: OCD vs TTM
DOMAIN OCD (N = 95) TTM (N = 30) Mann-Whitney U
Median Min Max Median Min Max Z P
School 1.0 0 4.0 1.0 0 4.0 -1.2 NS
Work 2.0 0 4.0 1.0 0 3.0 3.7 <0.001
Family 2.0 0 4.0 1.0 0 4.0 2.4 0.02
Marriage / dating 2.0 0 4.0 1.0 0 4.0 3.1 0.002
Friendships 1.0 0 4.0 1.0 0 3.0 1.1 NS
Other activities 2.0 0 4.0 0 0 3.0 2.3 0.02
Activities of daily life 2.0 0 4.0 0 0 3.0 5.5 <0.001
Suicide 1.0 0 4.0 0 0 3.0 2.6 0.009
Total disability 12.0 1.0 26.0 6.5 0 18.0 3.3 <0.001
Table 5: Temperament and Character Inventory: OCD vs TTM
TEMPERAMENT / 
CHARACTER 
TRAITS*
OCD (N = 68) TTM (N = 21) F P
NS 17.6 (6.8) 21.6 (6.0) .5 .02
HA 22.3 (7.9) 15.8 (7.3) .4 .001
RD 22.3 (4.2) 21.8 (4.9) .4 NS
SD 25.1 (8.2) 28.2 (9.6) .7 NS
C 30 (5.1) 29.3 (6.8) 2.8 NS
ST 15.2 (6.7) 21.3 (18.3) 5.0 NS
* NS = novelty seeking total score SD = self-directedness total score
HA = harm avoidance total score C = cooperativeness total score
RD = reward dependence total score ST = self-transcendence total scorePage 5 of 10
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Female OCD and TTM patients did not differ significantly
in terms of the impact of premenstrual/menstrual/meno-
pausal symptoms on their illness. Compared to 42
(38.5%) of 109 OCD patients who reported OC symptom
changes in the premenstrual/menstrual period, 16 of 32
TTM patients (50%) reported regular changes in their
symptoms during this time. Seventeen (n = 17) OCD
patients were menopausal and 35.3% (n = 6) of these
women reported that their OC symptoms only started
with menopause. One of the TTM patients had gone
through menopause with no effect on her hair-pulling
symptoms. However, OCD and TTM patients differed sig-
nificantly in terms of the temporal association between
pregnancy/puerperium and onset of illness: 42.6% (26 of
61) OCD patients reported OCD onset while pregnant or
within a month of childbirth, compared to 7.7% (1 of 13)
of TTM patients (χ2 = 6.8; p = .009).
Treatment response
Significantly fewer TTM patients reported a clinical
response to either CBT- or SRI-treatment than did OCD
patients (Table 2).
Discussion
A comparison of women with TTM and with OCD found
significant differences in clinical variables; OCD patients
had more comorbidity, greater disability, increased
childhood interpersonal trauma (specifically sexual
abuse) and more maladaptive schemas. Fewer TTM
patients, however, reported having responded to
treatment.
The gender ratio findings in both OCD and TTM groups
were similar to other surveys where a mean female:male
ratio of 1.5:1.0 in OCD [11,32,33] and approaching 10:1
in TTM [34] were documented. OCD patients' mean total
score on the YBOCS (i.e. 20.1 ± 8.0) puts them in the
"moderate" severity category [22]. The mean hair-pulling
severity score on the MGHHPS (16.1 ± 6.5) was similar to
that reported in other studies [35,36]. Taken together,
these data suggest that our patients are not dissimilar from
those assessed at other sites.
Our comorbidity findings are consistent with existing data
suggesting that depressive and anxiety disorders are highly
prevalent in both OCD and TTM, and significantly more
prevalent in OCD [3,16,18]. Indeed, compared to TTM,
comorbidity in OCD is greater across a range of different
diagnostic categories including mood (MDD, dysthymia),
anxiety (panic disorder), OCD-related (hypochondriasis)
and personality disorders (OCPD). Such comorbidity
appears to extend also to impulse control disorders (inter-
mittent explosive disorder), a finding which argues
against the current classification of trichotillomania as a
member of this spectrum of conditions.
Our findings of increased disability in OCD is consistent
with studies on OCD suggesting it is one of the most
impairing of all medical disorders [37]. A number of clin-
ical studies have emphasized the burden of OCD across
different domains, including higher rates of divorce and
separation than in subjects without OCD [13] and signif-
icantly impaired instrumental functioning (work, school,
home making and family life) [38-41]. However, the
Table 7: OCD and TTM scores on the YSQ subscales
Schemas OCD (n = 59) TTM (n = 26) Mann-Whitney U
Median Min Max Median Min Max Z P
Emotional deprivation 2.4 1.0 5.6 2.3 1.0 5.4 -0.6 NS
Abandonment 2.8 1.0 6.0 2.1 1.2 6.0 -0.5 NS
Mistrust / abuse 2.6 1.0 5.8 1.9 1.9 5.4 -2.3 .02
Social isolation 2.4 1.0 6.0 1.9 1.9 6.0 -2.7 .007
Shame / defectiveness 2.2 1.0 6.0 1.4 1.4 4.8 -3.0 .003
Failure to achieve 2.0 1.0 6.0 1.9 1.9 4.8 -0.9 NS
Incompetence 2.0 1.0 4.8 1.8 1.8 4.4 -1.2 NS
Vulnerability to harm 2.2 1.0 6.0 1.6 1.6 5.2 -1.8 NS
Enmeshment 1.8 1.0 6.0 1.7 1.7 4.2 -0.6 NS
Subjugation 2.2 1.0 6.0 1.7 1.7 5.6 -2.8 .005
Self-sacrifice 3.4 1.2 6.0 3.2 3.2 5.8 -1.0 NS
Emotional inhibition 2.4 1.0 5.0 1.4 1.4 4.4 -3.8 <.001
Unrelenting standards 3.8 1.2 6.0 3.6 3.6 6.0 -0.9 NS
Entitlement 2.6 1.0 5.8 2.7 2.7 6.0 -0.7 NS
Self-discipline 3.0 1.2 6.0 2.8 2.8 4.8 -1.3 NSPage 6 of 10
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estimated: TTM can be associated with serious sociologi-
cal and psychological effects (e.g. strong feelings of shame
and embarrassment [42], as well as avoidance behaviour
including potentially dangerous avoidance of medical
care [43]) resulting in a significant decline in quality of
life (QOL) for patients, their family members and signifi-
cant others [44,45].
OCD patients reported significantly more sexual abuse
than TTM patients (p = .04). This finding differs from our
previous data suggesting similar rates of childhood inter-
personal trauma (CIT) in OCD and TTM [46]. However,
the current sample size is much increased, resulting in
more power to detect smaller differences. Indeed,
increased rates of OCD (and other anxiety disorders) have
previously been linked with a history of physical and sex-
ual abuse during childhood [47,48]. Nevertheless, in both
OCD and TTM, dissociative symptoms – which are
present in a minority of patients in both conditions – are
positively correlated with a history of childhood interper-
sonal trauma [49], so that a potential role for CIT in some
TTM patients should not be ignored [50].
TTM patients had significantly more novelty seeking (NS)
than OCD patients, whereas OCD patients scored signifi-
cantly higher on harm avoidance (HA) compared to TTM.
Our findings are consistent with previous work on tem-
perament / character in OCD, showing increased HA and
decreased NS [51-53]. Of note, compared with mean tem-
perament scores obtained in a normal community sample
[30], both TTM and OCD scored high on HA. NS scores in
the TTM sample were higher than in the OCD sample, but
compared to normal controls, these fell in the "medium"
range. The higher NS in TTM may however point to greater
dopaminergic involvement in this disorder, and might
also be used to argue that TTM lies closer to the more
impulsive risk-/novelty-seeking pole of an impulsive-
compulsive (IC) spectrum of disorders [54].
OCD patients had more maladaptive cognitive schemas
than TTM, i.e. mistrust / abuse, social isolation, shame /
defectiveness, subjugation and emotional inhibition. The
schemas that OCD and TTM patients differed on are
included in 2 of the 4 higher order factors (i.e. "impaired
autonomy" and "disconnection") described by Lee and
colleagues' YSQ factor model [55]. While schemas are
thought to represent responses to life experience, includ-
ing the experience of a disorder, they may also reflect
underlying symptoms. Given that maladaptive schemas
in OCD were not reminiscent of its characteristic symp-
toms, it is likely that they at least partly reflect life experi-
ence. An increased number of maladaptive schemas in
OCD is consistent with higher rates of comorbidity, disa-
bility, and functional impairment. Nevertheless, further
empirical investigation is needed to assess the relation-
ship between schemas and illness course.
Hormonal influences have previously been investigated
in OCD [56] and TTM [57]. For example, it has been
noted that menarche, premenstruum, pregnancy [58],
and menopause [59] may be related to onset or relapse in
OCD. Similarly, in a study that investigated the relation-
ship of the menstrual cycle and pregnancy to compulsive
hair-pulling, premenstrual symptom exacerbation was
reported for actual hair-pulling, urge intensity and fre-
quency, and ability to control pulling [57]. In that study
the impact of pregnancy on TTM was less clear. Our find-
ings suggest that significantly more OCD patients than
TTM patients report an association between pregnancy/
puerperium and the onset of illness. This finding is in part
consistent with previous work suggesting that the
postpartum may constitute a risk for the onset of OCD in
women [60]. Taken together our data suggest both simi-
larities and differences in the role of sexual hormones in
the mediation of OCD and TTM.
Although rare, brain injury may play a role in some cases
of OCD [61,62]; in only one OCD patient (and none of
the TTM patients), head injury was associated with onset
of obsessive-compulsive symptoms. No data could be
found on the potential role of brain injury in the etiology
of hair-pulling.
A number of patients associated the onset of their OCD
onset with an infection, possibly bacterial pharyngitis.
This finding is consistent with a body of data suggesting
post-streptococcal disease is a cause of OCD in children
and adolescents [63], and perhaps also adults [64,65].
There is less work demonstrating a role for autoimmune
factors in TTM [66]. Notably, the data on bacterial phar-
yngitis were based on retrospective assessment and could
have been contaminated by memory bias.
In our study, more OCD patients reported a positive
response to treatment (with CBT or SRI's) than TTM
patients. These data should be interpreted cautiously
given the retrospective assessments. Nevertheless, there is
evidence that SRI's in TTM may not be as effective over the
long-term as in OCD [2]. About 40–60% of OCD patients
respond to the first trial of an SRI [67], with a proportion
of non-responders to a single SRI responding to adminis-
tration of a second SRI [68]. In comparison, it has been
suggested that TTM patients judge their treatment (includ-
ing pharmacotherapy, psychotherapy, and behaviour
modification) to be relatively ineffective [69]. The useful-
ness of SRI's in TTM has been investigated in a number of
studies with results so far being equivocal. For example,
Christenson et al [70] were unable to document efficacy
for fluoxetine in a placebo-controlled trial in whichPage 7 of 10
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to 80 mg/day. Anecdotal evidence also suggests that the
effectiveness of SRI's in TTM may wane with time [71].
Although there is evidence for the usefulness of behaviour
therapy in both OCD [72] and TTM [73], the focus of the
treatment differs in the two disorders (exposure and
response prevention in OCD versus habit reversal in
TTM). Keuthen et al [74] have suggested that "state-of-the-
art" behavioral and pharmacological treatments offer sub-
stantial clinical benefit to patients with TTM, but in gen-
eral clinics there may be relatively little experience with
highly specialized interventions.
Several limitations of the current study should be
acknowledged. First, interviewers were not blind to the
patients' psychiatric diagnosis, so potentially biasing cli-
nician's assessments. Nevertheless, a structured diagnostic
instrument ensures a reasonable degree of reliability. Sec-
ond, instruments employed in the current study are
intended for use in adults rather than younger subjects.
However, in the case of children and adolescents, the
SCID-I was supplemented with a clinical interview of par-
ents or guardians, and self-report data was included only
when it was clear that questionnaires had been completed
meaningfully. Third, source of referral, and the duration
of OCD/TTM, were not controlled for in the analysis, so
potentially biasing the analyses. However, given the chro-
nicity of both conditions, this is unlikely to have materi-
ally affected the findings. Fourth, males, as well as patients
with comorbid OCD and TTM were excluded from the
investigation; so that the results here may not be general-
izable to all OCD or TTM subjects. Given evidence that the
phenotype of OCD [75] and of TTM [10] varies with gen-
der, additional work on male subjects should be under-
taken in the future.
Conclusions
In conclusion, our data suggest that despite some overlap,
TTM differs from OCD in terms of demographics (gender
distribution), associated clinical variables (e.g. comorbid-
ity, cognitive schemas, temperament/character profiles
and disability), precipitating factors (trauma history) and
treatment response. It has been suggested that although
TTM is not the same as OCD, it lies on a compulsive-
impulsive spectrum of disorders [54]. However, it is nota-
ble that impulsivity may be an important component of
OCD [76], and rather than viewing OCD and TTM on a
single dimension, compulsivity and impulsivity should
arguably therefore be seen as lying on orthogonal dimen-
sions. Although TTM patients had more novelty seeking,
OCD patients were more likely to have intermittent explo-
sive disorder; such data support a view that TTM should
not be classified as an impulse control disorder. Indeed,
TTM may have more in common with conditions charac-
terized by stereotypical self-injurious symptoms, such as
skin-picking [77]. Differences between OCD and TTM
may reflect contrasts in underlying psychobiology, and
may necessitate contrasting treatment approaches.
Competing interests
The author(s) declare that they have no competing
interests.
Authors' contributions
CL:
• participated in the design of the study,
• was responsible for patient recruitment,
• did most of the clinical assessments,
• performed the statistical analyses,
• helped to obtain funds for the research, and
• was responsible for the final writing up of data.
SS:
• participated in the design of the study,
• assisted with recruitment of patients, and
• supervised writing and statistical analyses.
PLduT:
• participated in the design of the study,
• assisted with recruitment of patients, and
• did some of the clinical assessments.
DGN:
Table 6: TCI-temperament cut-off scores: A normal community 
sample*
TCI – TEMPERAMENT TRAITS
NS HA
LOW MEDIUM HIGH LOW MEDIUM HIGH
16 19.5 22 8 12.5 16
*from Cloninger et al, 1994 (reference nr. 31)Page 8 of 10
(page number not for citation purposes)
BMC Psychiatry 2005, 5:2 http://www.biomedcentral.com/1471-244X/5/2• was the primary statistical consultant for analyses.
DJHN:
• participated in the design and coordination of the study,
• was responsible for patient recruitment, and
• assisted with clinical assessments.
RS:
• assisted with literature review of cognitive schema data,
and
• asisted statistical analysis of schema data.
DJS:
• conceived of the study
• supervised coordination, statistical analysis, and
writing,
• did the final revision of paper before submission, and
• assisted with obtaining of funds.
All authors read and approved the final manuscript.
Acknowledgements
This work is supported by the Medical Research Council of South Africa, 
the National Research Foundation, and by a grant from the Obsessive-
Compulsive Foundation. The help of the Obsessive-Compulsive Associa-
tion of South Africa is gratefully acknowledged.
References
1. American Psychiatric Association: Diagnostic and statistical manual of
mental disorders 4th edition. Washington DC: American Psychiatric
Association; 1994. 
2. Stein DJ, Simeon D, Cohen LJ, Hollander E: Trichotillomania and
obsessive-compulsive disorder. J Clin Psychiatry 1995, 56(Suppl
4):28-34.
3. Tukel R, Keser V, Karali N, Olgun T, Calikusu C: Comparison of
clinical characteristics in trichotillomania and obsessive-
compulsive disorder. J Anxiety Disord 2001, 15:433-441.
4. Swedo SE: Is trichotillomania an obsessive-compulsive spec-
trum disorder? In The obsessive-compulsive related disorders Edited
by: Hollander E. Washington, DC: American Psychiatric Press; 1993. 
5. Ninan P, Mansueto C, Rothbaum B, O'Sullivan R, Nemcroff C: Chal-
lenges in the classification and treatment of trichotillomania.
CNS Spectrums 1998, 3:30-35.
6. Swedo SE, Leonard HL: Trichotillomania. An obsessive compul-
sive spectrum disorder? Psychiatr Clin North Am 1992, 15:777-790.
7. Stein DJ, Mullen L, Islam MN, Cohen L, DeCaria CM, Hollander E:
Compulsive and impulsive symptomatology in
trichotillomania. Psychopathology 1995, 28:208-213.
8. Swedo S: Trichotillomania. In Obsessive-compulsive related disorders
Edited by: Hollander E. Washington DC: American Psychiatric Press,
Inc; 1993:93-111. 
9. Swedo SE, Leonard HL, Rapoport JL: Childhood-onset obsessive
compulsive disorder. Psychiatr Clin North Am 1992, 15:767-775.
10. Christenson GA, Mackenzie TB, Mitchell JE: Adult men and
women with trichotillomania. A comparison of male and
female characteristics. Psychosomatics 1994, 35:142-149.
11. Weissman MM, Bland RC, Canino GJ, Greenwald S, Hwu HG, Lee
CK, Newman SC, Oakley-Browne MA, Rubio-Stipec M, Wickrama-
ratne PJ: The cross national epidemiology of obsessive com-
pulsive disorder. The Cross National Collaborative Group. J
Clin Psychiatry 1994, 55(Suppl):5-10.
12. du Toit PL, van Kradenburg J, Niehaus DJH, Stein DJ: Characteris-
tics and phenomenology of hair-pulling: An exploration of
subtypes. Compr Psychiatry 2001, 42:247-256.
13. Regier DA, Narrow WE, Rae DS: The epidemiology of anxiety
disorders:The Epidemiologic Catchment Area (ECA)
experience. J Psychiatr Res 1990, 24(Suppl 2):3-14.
14. Rettew DC, Swedo SE, Leonard HL, Lenane MC, Rapoport JL:
Obsessions and compulsions across time in 79 children and
adolescents with obsessive-compulsive disorder. J Am Acad
Child Adolesc Psychiatry 1992, 31:1050-1056.
15. Bogetto F, Venturello S, Albert U, Maina G, Ravizza L: Gender-
related clinical differences in obsessive-compulsive disorder.
Eur Psychiatry 1999, 14:434-441.
16. Stanley MA, Swann AC, Bowers TC, Davis ML, Taylor DJ: A com-
parison of clinical features in trichotillomania and obsessive-
compulsive disorder. Behav Res Ther 1992, 30:39-44.
17. Baer L: Behavioral therapy for obsessive-compulsive disorder
and trichotillomania: Implications for Tourette's syndrome.
In Advances in neurology Edited by: Chase TN, Friedhoff AJ, Cohen DJ.
New York: Raven Press; 1992:333-340. 
18. Himle JA, Bordnick PS, Thyer BA: A comparison of trichotilloma-
nia and obsessive-compulsive disorder. Journal of Psychopathology
and Behavioral Assessment 1995, 17:251-260.
19. Stanley MA, Bowers TC, Swann AC: Trichotillomania and obses-
sive-compulsive disorder. New Research Program and Abstracts,
143rd meeting of the APA, NY [NR292], 158 1990. Abstract
20. First MB, Spitzer RL, Gobbon M, Williams JBW: Structured clinical inter-
view for DSM-IV Axis I disorders – Patient edition (SCID-I/P, Version 2.0, 8/
98 revision) New York: New York State Psychiatric Institute, Biomet-
rics Research Department; 1998. 
21. du Toit PL, van Kradenburg J, Niehaus D, Stein DJ: Comparison of
obsessive-compulsive disorder patients with and without
comorbid putative obsessive-compulsive spectrum disor-
ders using a structured clinical interview. Compr Psychiatry 2001,
42:291-300.
22. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL,
Hill CL, Heninger GR, Charney DS: The Yale-Brown Obsessive
Compulsive Scale. I. Development, use, and reliability. Arch
Gen Psychiatry 1989, 46:1006-1011.
23. Keuthen NJ, O'Sullivan RL, Sprich-Buckminster S: Trichotilloma-
nia: current issues in conceptualization and treatment. Psy-
chother Psychosom 1998, 67:202-213.
24. Guy W: ECDEU Assessment Manual for Psychopharmacol-
ogy. Publication No. 76 – 338. Washington D.C., Superintendent of Doc-
uments, U.S. Government Printing Office, U.S. Department of Health,
Education, and Welfare. Report 1976.
25. Schneier FR, Heckelman LR, Garfinkel R, Campeas R, Fallon BA,
Gitow A, Street L, Del Bene D, Liebowitz MR: Functional impair-
ment in social phobia. J Clin Psychiatry 1994, 55:322-331.
26. Mogotsi M, Kaminer D, Stein DJ: Quality of life in the anxiety
disorders. Harv Rev Psychiatry 2000, 8:273-282.
27. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory
for measuring depression. Arch Gen Psychiatry 1961, 4:561-571.
28. Bernstein DP, Fink L, Handelsman L, Foote J, Lovejoy M, Wentzel K,
Sapareto E, Ruggiero J: Initial reliability and validity of a new ret-
rospective measure of child abuse and neglect. Am J Psychiatry
1994, 151:1132-1136.
29. Bernstein DP, Ahluvalia T, Pogge D, Handelsman L: Validity of the
Childhood Trauma Questionnaire in an adolescent psychiat-
ric population. J Am Acad Child Adolesc Psychiatry 1997, 36:340-348.
30. Cloninger CR, Przybeck TR, Svrakic DM, Wetzel RD: The Tempera-
ment and Character Inventory: A guide to its development and use Mis-
souri: Center for Psychobiology of Personality, Washington
University, St. Louis; 1994. 
31. Young JE: Cognitive Therapy for Personality Disorders Florida: Profes-
sional Resource Press; 1994. 
32. Castle DJ, Deale A, Marks IM: Gender differences in obsessive
compulsive disorder. Aust N Z J Psychiatry 1995, 29:114-117.Page 9 of 10
(page number not for citation purposes)
BMC Psychiatry 2005, 5:2 http://www.biomedcentral.com/1471-244X/5/233. Rasmussen SA, Tsuang MT: The epidemiology of obsessive com-
pulsive disorder. J Clin Psychiatry 1984, 45:450-457.
34. Christensen H, Mackenzie T, Mitchell J: Adult men and women
with trichotillomania. Psychosomatics 1994, 35:142-149.
35. Stewart RS, Nejtek VA: An open-label, flexible dose study of
olanzapine in the treatment of trichotillomania. J Clin Psychiatry
2003, 64:49-52.
36. van Minnen A, Hoogduin KA, Keijsers GP, Hellenbrand I, Hendriks GJ:
Treatment of trichotillomania with behavioral therapy or
fluoxetine: a randomized, waiting-list controlled study. Arch
Gen Psychiatry 2003, 60:517-522.
37. Murray CJL, Lopez AD: Global burden of disease: A comprehensive
assessment of mortality and disability from diseases, injuries and risk factors
in 1990 and projected to 2020 Harvard: World Health Organization;
1996. 
38. Amir N, Freshman M, Foa EB: Family distress and involvement
in relatives of obsessive-compulsive disorder patients. J Anxi-
ety Disord 2000, 14:209-217.
39. Calvocoressi L, Lewis B, Harris M, Trufan SJ, Goodman WK,
McDougle CJ, Price LH: Family accommodation in obsessive-
compulsive disorder. Am J Psychiatry 1995, 152:441-443.
40. Emmelkamp PM, de Haan E, Hoogduin CA: Marital adjustment
and obsessive-compulsive disorder. Br J Psychiatry 1990,
156:55-60.
41. Stein DJ, Allen AJ, Bobes J, Figuera ML, Iikura Y, Koran LM, Hollander
E: Quality of life in obsessive-compulsive disorder. CNS
Spectrum 2000, 5:37-39.
42. Swedo SE, Rapoport J: Annotation: Trichotillomania. J Child Psy-
chol Psychiatry 1991, 32:401-409.
43. O'Sullivan RL, Keuthen NJ, Jenike MA, Gumley G: Trichotillomania
and carpal tunnel syndrome. J Clin Psychiatry 1996, 57:174.
44. Diefenbach GJ, Mouton-Odum S, Stanley MA: Affective correlates
of trichotillomania. Behav Res Ther 2002, 40:1305-1315.
45. O'Sullivan RL, Mansueto CS, Lerner EA, Miguel EC: Characteriza-
tion of trichotillomania. A phenomenological model with
clinical relevance to obsessive-compulsive spectrum
disorders. Psychiatr Clin North Am 2000, 23:587-604.
46. Lochner C, du Toit PL, Zungu-Dirwayi N, Marais A, van Kradenburg
J, Seedat S, Niehaus DJ, Stein DJ: Childhood trauma in obsessive-
compulsive disorder, trichotillomania, and controls. Depress
Anxiety 2002, 15:66-68.
47. Burnam MA, Stein JA, Golding JM, Siegel JM, Sorenson SB, Forsythe
AB, Telles CA: Sexual assault and mental disorders in a com-
munity population. J Consult Clin Psychol 1988, 56:843-850.
48. Stein MB, Walker JR, Anderson G, Hazen AL, Ross CA, Eldridge G,
Forde DR: Childhood physical and sexual abuse in patients
with anxiety disorders and in a community sample. Am J
Psychiatry 1996, 153:275-277.
49. Lochner C, Seedat S, Hemmings SMJ, Kinnear CJ, Corfield VA, Nie-
haus DJH, Moolman-Smook JC, Stein DJ: Dissociative experiences
in obsessive-compulsive disorder and trichotillomania: clini-
cal and genetic findings. Compr Psychiatry 2004, 45:384-391.
50. Boughn S, Holdom JJ: The relationship of violence and
trichotillomania. J Nurs Scholarsh 2003, 35:165-170.
51. Lyoo IK, Lee DW, Kim YS, Kong SW, Kwon JS: Patterns of tem-
perament and character in subjects with obsessive-compul-
sive disorder. J Clin Psychiatry 2001, 62:637-641.
52. Pfohl B, Black D, Noyes R, Kelley M, Blum N: A test of the tridi-
mensional personality theory: association with the diagnosis
and platelet imipramine binding in obsessive-compulsive
disorder. Biol Psychiatry 1990, 28:41-46.
53. Richter MA, Summerfeldt LJ, Joffe RT, Swinson RP: The Tridimen-
sional Personality Questionnaire in obsessive-compulsive
disorder. Psychiatry Res 1996, 65:185-188.
54. Stein DJ, Hollander E: The spectrum of obsessive-compulsive
related disorders. In Obsessive-compulsive related disorders Edited by:
Hollander E. Washington DC: American Psychiatric Press; 1993. 
55. Lee C, Taylor G, Dunn J: Factor structure of the schema ques-
tionnaire in a large clinical sample. Cognitive Therapy and Research
1999, 23:441-451.
56. Weiss M, Baerg E, Wisebord S, Temple J: The influence of gonadal
hormones on periodicity of obsessive-compulsive disorder.
Can J Psychiatry 1995, 40:205-207.
57. Keuthen NJ, O'Sullivan RL, Hayday CF, Peets KE, Jenike MA, Baer L:
The relationship of menstrual cycle and pregnancy to com-
pulsive hairpulling. Psychother Psychosom 1997, 66:33-37.
58. Neziroglu F, Anemone R, Yaryura-Tobias JA: Onset of obsessive-
compulsive disorder in pregnancy. Am J Psychiatry 1992,
149:947-950.
59. Rasmussen SA, Eisen JL: Clinical and epidemiologic findings of
significance to neuropharmacologic trials in OCD. Psychophar-
macol Bull 1988, 24:466-470.
60. Maina G, Albert U, Bogetto F, Vaschetto P, Ravizza L: Recent life
events and obsessive-compulsive disorder (OCD): the role of
pregnancy/delivery. Psychiatry Res 1999, 89:49-58.
61. Hibbard MR, Uysal S, Kepler K, Bogdany J, Silver J: Axis I psychopa-
thology in individuals with traumatic brain injury. J Head
Trauma Rehabil 1998, 13:24-39.
62. Hiott DW, Labbate L: Anxiety disorders associated with trau-
matic brain injuries. NeuroRehabilitation 2002, 17:345-355.
63. Swedo SE, Leonard H, Mittleman BB, Allan AJ, Rapoport JL, Dow SP,
Kanter ME, Chapman F, Zabriskie J: Identification of children with
pediatric autoimmune neuropsychiatric disorders associ-
ated with streptococcal infections by a marker associated
with rheumatic fever. Am J Psychiatry 1997, 154:110-112.
64. Bodner SM, Morshed SA, Peterson BS: The question of PANDAS
in adults. Biol Psychiatry 2001, 49:807-810.
65. Greenberg BD, Murphy DL, Swedo SE: Symptom exacerbation of
vocal tics and other symptoms associated with streptococcal
pharyngitis in a patient with obsessive-compulsive disorder
and tics. Am J Psychiatry 1998, 155:1459-1460.
66. Niehaus DJ, Knowles JA, Van Kradenberg J, du TW, Kaminer D,
Seedat S, Daniels W, Cotton M, Brink P, Beyers AD, Bouic P, Chap-
man F, Zabriskie JB, Stein DJ: D8/17 in obsessive-compulsive dis-
order and trichotillomania. S Afr Med J 1999, 89:755-756.
67. Jenike MA: Pharmacologic treatment of obsessive compulsive
disorders. Psychiatr Clin North Am 1992, 15:895-919.
68. Pigott TA, Pato MT, Bernstein SE, Grover GN, Hill JL, Tolliver TJ,
Murphy DL: Controlled comparisons of clomipramine and
fluoxetine in the treatment of obsessive-compulsive disor-
der. Behavioral and biological results. Arch Gen Psychiatry 1990,
47:926-932.
69. Boughn S, Holdom JA: Trichotillomania: women's reports of
treatment efficacy. Res Nurs Health 2002, 25:135-144.
70. Christenson GA, Mackenzie TB, Mitchell JE, Callies AL: A placebo-
controlled, double-blind crossover study of fluoxetine in
trichotillomania. Am J Psychiatry 1991, 148:1566-1571.
71. Pollard CA, Ibe IO, Krojanker DN, Kitchen AD, Bronson SS, Flynn
TM: Clomipramine treatment of trichotillomania: a follow-
up report on four cases. J Clin Psychiatry 1991, 52:128-130.
72. Baer L: Behavior therapy for obsessive-compulsive disorder in
the office-based practice. J Clin Psychiatry 1993, 54(6 suppl):10.
73. Friman P, Finney J, Christerpherson E: Behavioral treatment of
trichotillomania: An evaluative overview. Behavior Therapy
1987, 15:249-264.
74. Keuthen NJ, O'Sullivan RL, Goodchild P, Rodriguez D, Jenike MA,
Baer L: Retrospective review of treatment outcome for 63
patients with trichotillomania. Am J Psychiatry 1998, 155:560-561.
75. Lochner C, Stein DJ: Gender in obsessive-compulsive disorder
and obsessive-compulsive spectrum disorders: A literature
review. Archives of Women's Mental Health 2001, 4:19-26.
76. Lochner C, Hemmings SMJ, Kinnear C, Niehaus DJH, Nel DG, Cor-
field VC, Moolman-Smook JC, Seedat S, Stein DJ: Cluster analysis
of obsessive-compulsive spectrum disorders in patients with
obsessive-compulsive disorder: Clinical and genetic
correlates. Compr Psychiatry 2004, 46:14-19.
77. Lochner C, Simeon D, Niehaus DJH, Stein DJ: Trichotillomania
and skin-picking: a phenomenological comparison. Depress
Anxiety 2001, 15:83-86.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-244X/5/2/prepubPage 10 of 10
(page number not for citation purposes)
